← All stocks

Quince Therapeutics, Inc.

QNCX Net selling
CIK 0001662774 #4870 in the set updated 18 Sep 2026
Bought (120 mo)
$11.88M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$29.23M
$0.00 on a plan · $9.71M straight out of an exercise
Sold at will
$19.52M
32 of 63 sales
Net
−$17.34M
−$7.63M against sales at will

By person

21 insiders · 141 transactions
6.2×

Dirk Thye holds 6.2 times base salary in stock. $3.45M of shares against $550.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dirk Thye last reported holding, valued at $3.47, the price Common Stock was last bought or sold at on the open market here, on 26 Dec 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
PFIZER INC entity
10% owner
$850.00K (1)
$14.87M (1)
−$14.02M
2,879,973
$9.99M
Lamond David
Director
$8.65M (32)
+$8.65M
8,031,665
$27.87M
+120.2%
Lynch Casey
Chief Executive Officer
$4.41M (25)
−$4.41M
1,180,580
$4.10M
−4.8%
Detke Michael J.
Chief Medical Officer
$4.15M (9) scheduled
−$4.15M
140,000
$485.80K
LOWE CHRISTOPHER P.
Interim CEO, COO & CFO
$3.67M (10) scheduled
−$3.67M
265,000
$919.55K
EPIQ Capital Group, LLC entity
IA/Managing Member of 10% Owne
$1.33M (15)
+$1.33M
19,880,610
$68.99M
+0.1%
Holsinger Leslie
EVP, Preclinical Development
$1.23M (6) scheduled
−$1.23M
148,080
$513.84K
McLoughlin Margaret
Director
$19.19K (2)
$691.91K (9) scheduled
−$672.72K
8,000
$27.76K
YOUNG KEVIN
Director
$510.00K (1)
+$510.00K
30,000
$104.10K
Thye Dirk
CEO and CMO
$317.46K (4)
+$317.46K
994,885
$3.45M
+359.9%
Benatti Luca
Director
$173.50K (1)
−$173.50K
39,179
$135.95K
−51.2%
Hannah Brendan
CBO, COO & CCO
$111.72K (7)
+$111.72K
361,827
$1.26M
+218.6%
RYAN UNA S
Director
$48.88K (1)
+$48.88K
2,875
$9.98K
Ryan Charles S.
President
$31.45K (1)
+$31.45K
130,009
$451.13K
+75.5%
McDowell Caryn Gordon
Chief Legal & Adm. Officer
$30.92K (1)
−$30.92K
122,500
$425.08K
Dominy Stephen S.
Chief Scientific Officer
$10.99K (1)
+$10.99K
1,217,086
$4.22M
+0.1%
Monohon Ted
Chief Accounting Officer & VP
$1.83K (1)
−$1.83K
27,440
$95.22K
LAMOND PIERRE
10% owner
2,886,530
$10.02M
Takeda Ventures, Inc. entity
10% owner
2,679,802
$9.30M
Low Philip S
Director
519,283
$1.80M
Smith Karen L.
Chief Medical Officer
24,336
$84.45K

No percentages here. This company's share count has moved by a factor of 160.3 over the window, from 1,017,063 to 163,007,943 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Benatti Luca
26 Dec 2025
Director
Sell
50,000
$3.47
$173.50K
Monohon Ted
6 Mar 2023
Chief Accounting Officer & VP
Sell
1,871
$0.98
$1.83K
McDowell Caryn Gordon
6 Jun 2022
Chief Legal & Adm. Officer
Sell
10,800
$2.86
$30.92K
McLoughlin Margaret
28 Jun 2021
Director
Sell
100
$55.73
$5.57K
McLoughlin Margaret
28 Jun 2021
Director
Sell
250
$55.03
$13.76K
McLoughlin Margaret
28 Jun 2021
Director
Sell
200
$55.01
$11.00K
Lynch Casey
10 May 2021
Chief Executive Officer
Sell indirect
183
$36.73
$6.72K
Lynch Casey
10 May 2021
Chief Executive Officer
Sell indirect
6,315
$35.81
$226.14K
Lynch Casey
10 May 2021
Chief Executive Officer
Sell indirect
9,918
$34.89
$346.04K
Lynch Casey
10 May 2021
Chief Executive Officer
Sell indirect
13,584
$33.75
$458.46K
Lynch Casey
22 Mar 2021
Chief Executive Officer
Sell indirect
400
$36.60
$14.64K
Lynch Casey
22 Mar 2021
Chief Executive Officer
Sell indirect
300
$36.58
$10.97K
Lynch Casey
22 Mar 2021
Chief Executive Officer
Sell indirect
18,089
$35.85
$648.49K
Lynch Casey
22 Mar 2021
Chief Executive Officer
Sell indirect
11,211
$35.10
$393.51K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
600
$45.73
$27.44K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
8,032
$45.00
$361.44K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
1,900
$44.22
$84.02K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
1,512
$43.10
$65.17K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
3,100
$41.91
$129.92K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
2,000
$40.84
$81.68K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
856
$39.82
$34.09K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
1,600
$38.64
$61.82K
Lynch Casey
3 Feb 2021
Chief Executive Officer
Sell indirect
400
$37.39
$14.96K
Lynch Casey
2 Feb 2021
Chief Executive Officer
Sell indirect
5,071
$36.75
$186.36K
Lynch Casey
2 Feb 2021
Chief Executive Officer
Sell indirect
14,929
$36.02
$537.74K
Lynch Casey
1 Feb 2021
Chief Executive Officer
Sell indirect
371
$39.23
$14.55K
Lynch Casey
1 Feb 2021
Chief Executive Officer
Sell indirect
100
$38.28
$3.83K
Lynch Casey
1 Feb 2021
Chief Executive Officer
Sell indirect
4,283
$37.68
$161.38K
Lynch Casey
1 Feb 2021
Chief Executive Officer
Sell indirect
7,460
$36.56
$272.74K
Lynch Casey
1 Feb 2021
Chief Executive Officer
Sell indirect
3,100
$35.59
$110.33K
Lynch Casey
1 Feb 2021
Chief Executive Officer
Sell indirect
4,686
$34.60
$162.14K
PFIZER INC
3 Jun 2020
10% owner
Sell
370,000
$40.18
$14.87M

What was left out

Form 4 filings counted 164
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 10
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 31
Sales at will 32
Transactions with no price 0
Shares from compensation/vesting 16,076,553
Sales filed before the plan box existed 31
History held since 9 May 2019